CAS 62952-06-1

Aspisol

Descripción:

Aspisol, con el número CAS 62952-06-1, es un compuesto químico conocido principalmente por su aplicación en la industria farmacéutica, particularmente como un fármaco antiinflamatorio no esteroideo (AINE). Exhibe propiedades analgésicas, antipiréticas y antiinflamatorias, lo que lo hace útil para tratar el dolor, la fiebre y la inflamación. Aspisol funciona inhibiendo las enzimas ciclooxigenasas (COX), que juegan un papel crucial en la síntesis de prostaglandinas, compuestos que median la inflamación y el dolor. La sustancia se administra típicamente en varias formulaciones, incluyendo tabletas y aplicaciones tópicas, y se caracteriza por su perfil de toxicidad relativamente bajo en comparación con otros AINE. Sin embargo, como todos los medicamentos, puede tener efectos secundarios, incluyendo malestar gastrointestinal y riesgos cardiovasculares potenciales, particularmente con el uso a largo plazo. Su farmacocinética implica procesos de absorción, distribución, metabolismo y excreción que son esenciales para determinar su eficacia y seguridad en el uso clínico. En general, Aspisol es un compuesto significativo en el ámbito del manejo del dolor y el control de la inflamación.

Fórmula: C₉H₈O₄·C₆H₁₄N₂O₂

InChI: InChI=1S/C9H8O4.C6H14N2O2/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;7-4-2-1-3-5(8)6(9)10/h2-5H,1H3,(H,11,12);5H,1-4,7-8H2,(H,9,10)

Clave InChI: InChIKey=JJBCTCGUOQYZHK-UHFFFAOYSA-N

SMILES: C(CCCCN)(C(O)=O)N.C(O)(=O)C1=C(OC(C)=O)C=CC=C1

Sinónimos:

• 2,6-Diaminohexanoic Acid Compound With 2-Acetoxybenzoic Acid (1:1)
• 6-Ammonionorleucine 2-(Acetyloxy)Benzoate
• <span class="text-smallcaps">DL</span>-Lysine acetylsalicylate
• <span class="text-smallcaps">DL</span>-Lysine aspirin salt
• <span class="text-smallcaps">DL</span>-Lysine, mono[2-(acetyloxy)benzoate]
• Acelysin
• Acelysine
• Acetylsalicylic acid <span class="text-smallcaps">DL</span>-lysine salt
• Acetylsalicylic acid dl-lysine salt
• Acetylsalicylic acid lysine salt
• Asalis
• Aspegic
• Aspidol
• Aspirin <span class="text-smallcaps">D</smallcap><smallcap>L</span>-lysine
• Aspirin DL-lysine
• Aspirin Lysine
• Aspirin lysine salt
• Aspirisine
• Aspisol
• Atselizin
• Benzoic acid, 2-(acetyloxy)-, compd. with <span class="text-smallcaps">DL</span>-lysine (1:1)
• Benzoic acid, 2-(acetyloxy)-, compd. with lysine (1:1)
• Cogla
• DL-Lysine acetylsalicylate
• Delgesic
• Egicalm
• Laboprin
• Lysal
• Lysine acetylsalicylate
• Lysine monosalicylate acetate
• Lysine, 2-(acetyloxy)benzoate (1:1)
• Lysine, mono[2-(acetyloxy)benzoate]
• Lysini racemici acetylsalicylase
• Quinvet
• Solpirin
• Venopirin
• Vetalgina
• Vetalgine
• o-Acetylsalicylic acid <span class="text-smallcaps">D</smallcap>,<smallcap>L</span>-lysine salt
• DL-Lysine, mono[2-(acetyloxy)benzoate]

DL-LYSINE ACETYLSALICYLATE CRS

CAS: 62952-06-1

DL-LYSINE ACETYLSALICYLATE CRS

Ref: 41-Y0002211

DL-Lysine Acetylsalicylate

CAS: 62952-06-1

Fórmula: C₁₅H₂₂N₂O₆

Pureza: 98%

Forma y color: Solid

Peso molecular: 326.3450

Ref: IN-DA01CC6I

DL-Lysine Acetylsalicylate

CAS: 62952-06-1

Fórmula: C₉H₈O₄·C₆H₁₄N₂O₂

Pureza: >98.0%(T)(HPLC)

Forma y color: White to Light yellow powder to crystal

Peso molecular: 326.35

Ref: 3B-A3744

DL-Lysine Acetylsalicylate

Producto controlado

CAS: 62952-06-1

Applications Non-steroidal anti-inflammatory drugs (NSAIDs) may inhibit cancer growth. Water soluble, injectable aspirin derivative.Analgesic; antipyretic; anti-inflammatory.
References Korttila, K., et al.: Br. J. Anaesth, 52, 613 (1980), Diaz, C., et al.: Clin. Ther., 4, 121 (1981), Wolff, F., et al.: Arch. Gynecol., 233, 15 (1982), Bretagne, J.-F., et al.: Gastroenterol. Clin. Biol., 8, 28 (1984),

Fórmula: C₉H₈O₄·C₆H₁₄N₂O₂

Forma y color: Neat

Peso molecular: 326.34

Ref: TR-L488500

Aspirin DL-lysine

CAS: 62952-06-1

Aspirin DL-lysine: a water-soluble, injectable NSAID that may also hinder cancer growth.

Fórmula: C₁₅H₂₂N₂O₆

Forma y color: Crystalline Solid

Peso molecular: 326.35

Ref: TM-T20458

DL-Lysine acetylsalicylate

CAS: 62952-06-1

L-Lysine acetylsalicylate is a nonsteroidal anti-inflammatory drug that has been shown to have analgesic and anti-inflammatory properties. L-Lysine acetylsalicylate has been shown to inhibit the activity of the enzyme cyclooxygenase, which is responsible for the production of prostaglandins from arachidonic acid. This inhibition leads to decreased levels of prostaglandins and a decrease in inflammation. L-Lysine acetylsalicylate also inhibits the activity of platelets, which are necessary for blood clotting. It does not affect the brain infarction process, but does increase cerebral blood flow in glioma patients. L-Lysine acetylsalicylate has been shown to be an effective treatment against cervical cancer cells in cell culture experiments. The molecular weight of this compound is 584 Da and it contains 8 atoms of oxygen that can be replaced with chloride ions or acet

Fórmula: C₉H₈O₄•C₆H₁₄N₂O₂

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 326.35 g/mol

Ref: 3D-FL24964